• Episode 2: R3 Stem Cell Offers Exosomes as Therapeutic Systems

  • Nov 1 2022
  • Duración: 4 m
  • Podcast

Episode 2: R3 Stem Cell Offers Exosomes as Therapeutic Systems  Por  arte de portada

Episode 2: R3 Stem Cell Offers Exosomes as Therapeutic Systems

  • Resumen

  • Highly qualified providers offer Exosome Therapy treatments through injection, intravenous, nebulizer, or intranasal. Often, exosomes and mesenchymal stem cells are infused together for optimal results. These exosomes used by R3 Stem Cell Therapy are derived specifically from umbilical cord stem cells. These cells are produced in cGMP-compliant labs (Current Good Manufacturing Practice). The quality assurance standards are equitable to the necessary regulations provided by the US FDA (Food & Drug Administration). According to David Greene, the Founder, and CEO of R3 Stem Cell Therapy,
    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Episode 2: R3 Stem Cell Offers Exosomes as Therapeutic Systems

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.